We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 4,219

2017 Second Quarter Children’s Television Programming Documentation
  • Pillsbury Winthrop Shaw Pittman LLP
  • USA
  • July 5 2017

The next Children’s Television Programming Report must be filed with the FCC and placed in stations’ public inspection files by July 10, 2017

Shipping in Germany
  • Ahlers & Vogel
  • Germany, Global
  • July 4 2017

A structured guide to shipping laws in Germany

Biosimilar Notice May Be Given Prior to FDA Approval
  • McDermott Will & Emery
  • USA
  • June 26 2017

In a unanimous decision, the Supreme Court of the United States explained that under the Biologics Price Competition and Innovation Act of 2009

Something is better than nothing: court approval of liquidator entering litigation funding agreement
  • Corrs Chambers Westgarth
  • Australia
  • June 23 2017

This week’s TGIF considers In re City Pacific Limited in which the NSW Supreme Court considered whether to approve a liquidator entering into a

Advertiser Fined By FCC For Use Of Emergency Tones in Football Ads
  • Reed Smith LLP
  • USA
  • June 22 2017

The FCC entered into a settlement late last month with TEGNA, Inc. ("TEGNA") for $55,000. The case erupted after TEGNA used Emergency Alert System

Exaggerated Diagnosis Codes and Inadequate Provider Networks: Allegations of Medicare Advantage Fraud Settled for $32.5 Million
  • Baker & Hostetler LLP
  • USA
  • June 20 2017

The latest settlement involving Medicare Advantage (MA) organizations highlights not only the government’s continuing enforcement focus on Medicare

Sandoz Inc. v. Amgen Inc.
  • Merchant & Gould
  • USA
  • June 16 2017

In a unanimous decision in Sandoz Inc. v. Amgen Inc., the U.S. Supreme Court held that injunctive relief was not available under federal law to

USCIS Updates Policy Manual - Requires Sustainment of “At Risk” During Conditional Permanent Residency
  • Greenberg Traurig LLP
  • USA
  • June 15 2017

On June 14, 2017, USCIS issued a notice that it had revised its Policy Manual as it relates to the job creation and “at risk” requirements for EB-5

Supreme Court Dictates How Long Biosimilar Applicants Must Wait Before Bringing Approved Products to Market
  • Wolf Greenfield & Sacks PC
  • USA
  • June 13 2017

Over seven years after the Biologics Price Competition and Innovation Act (BPCIA) was signed into law, the Supreme Court has answered two

To Dance or Not to Dance: Supreme Court Held Patent Dance Under BPCIA Not Enforceable By Injunction Under Federal Law
  • Vinson & Elkins LLP
  • USA
  • June 13 2017

On June 12, 2017, the Supreme Court held that a biosimilar applicant cannot be enjoined under federal law to provide its application and manufacturing